Virco BVBA has signed a global research and development, non-exclusive licensing agreement with Siemens Healthcare Diagnostics.
Under the agreement, Siemens is providing Virco a license that will enable the company to develop and commercialise a hepatitis C research service testing platform.
This platform will initially be utilised by pharmaceutical companies for drug-development support of the hepatitis C virus (HCV) antivirals.
The platform will have the potential to provide HCV clinical diagnostic testing services in the future.